Who owns Nolpaza Control?
Nolpaza Control is owned by Krka (Slovenia, LJSE: KRKG).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Krka 2025 Annual Report, Krka, d. d., Novo mesto, 23 March 2026. Last checked .
Key facts
- Current owner
- Krka, tovarna zdravil, d. d., Novo mesto reported
- Owner HQ
- 🇸🇮 Slovenia, Novo mesto
- Origin
- 🇸🇮 Slovenia
- Category
- Consumer health › Over-the-counter medicine › Digestive health
- Parent ticker
- LJSE: KRKG WSE: KRK
- Last verified
- · 1 sources
About Nolpaza Control
Nolpaza Control is the over-the-counter form of Krka's pantoprazole, a proton pump inhibitor for stomach acid. The same medicine is sold on prescription as Nolpaza, and Emozul Control is the esomeprazole equivalent. Krka reports it as one of the leading non-prescription products for the gastrointestinal tract, holding more than a quarter of the category and first place in Slovakia and Lithuania. It is called Sedipanto in some markets.
Ownership timeline of Nolpaza Control
Where Nolpaza Control sits in Krka
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Krka ownership tree →
See the full Krka brand portfolio (18) →
Other brands owned by Krka
Krka controls 18 brands on Brandtree, 8 of them in consumer health.
Also in consumer health
Other brands in digestive health, and who owns them
The 25 brands in digestive health on Brandtree belong to 18 owners. The largest is Bayer, with 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Alka-Seltzer | Bayer | 🇩🇪 Germany |
| Daiichi Sankyo Stomach Medicine | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Kaopectate | Genomma Lab | 🇲🇽 Mexico |
| Epocler | Hypera | 🇧🇷 Brazil |
| Entrostop | Kalbe Farma | 🇮🇩 Indonesia |
| Metamucil | Procter & Gamble | 🇺🇸 United States |
| Buscolysin | Sopharma | 🇧🇬 Bulgaria |
| Oracal | Birzeit Pharmaceutical | 🇵🇸 Palestine |
About the owner: Krka
Krka is a publicly listed company headquartered in Novo mesto, Slovenia, founded in 1954. Brandtree records 18 brands under its control, and it is listed as LJSE: KRKG and WSE: KRK.
Krka is a Slovenian generic pharmaceutical maker established in Novo mesto in 1954, listed in Ljubljana since 1997 and dual-listed in Warsaw since 2012. Group revenue was €2,041.0 million in 2025 and net profit €403.7 million. Prescription medicines are the bulk of it, but Krka also sells non-prescription products and animal health products, and its Slovenian subsidiary Terme Krka runs four health resorts. At home it is the largest supplier of medicines by value and says one in every five medicines sold in Slovenia is its own.
🇸🇮 Nolpaza Control and other Slovenian brands
Brandtree records a controlling owner for 31 brands that began in Slovenia. 10 of them (32%) are now controlled by a company headquartered in another country; Nolpaza Control is not one of them.
Frequently asked questions
Who is the parent company of Nolpaza Control?
The parent company of Nolpaza Control is Krka, a publicly listed company headquartered in Slovenia.
Is Nolpaza Control Slovenian?
Yes. Nolpaza Control originated in Slovenia and its owner, Krka, is also headquartered in Slovenia.
Is Nolpaza Control still owned by Krka?
Yes. As of 16 September 2026, Nolpaza Control is still owned by Krka. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Krka 2025 Annual Report — Krka, d. d., Novo mesto, Annual report, published 23 March 2026; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.